CompletedNot Applicable

The Effect of the Use of Mobile App

Turkey (Türkiye)40 participantsStarted 2025-01-01

Plain-language summary

This randomized controlled trial aims to evaluate the effect of using the ABÖS-M mobile application, developed for mothers with newborns, on maternal knowledge, care skills, and self-efficacy levels related to Sudden Infant Death Syndrome (SIDS).

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Mothers with a healthy newborn baby, * Mothers who have not experienced any previous child loss, * Mothers with at least a primary school education, * Mothers who own a smartphone with mobile internet access, * Mothers who speak Turkish, are able to understand written and spoken information, follow instructions, and have no communication barriers, * Mothers who voluntarily agree to participate in the study. Exclusion Criteria: * Mothers with postpartum depression, * Mothers who do not complete the educational program within 15 days, * Mothers who request withdrawal from the study at any stage.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Knowledge

Timeframe: baseline (first assessment)

Knowledge

Timeframe: 2 weeks after from baseline

Knowledge

Timeframe: at the end of the invervention program (4 weeks after from baseline)

Care Skills

Timeframe: baseline (first assessment)

Care Skills

Timeframe: 2 weeks after from baseline

Care Skills

Timeframe: at the end of the invervention program (4 weeks after from baseline)

Self-Efficacy

Timeframe: baseline (first assessment)

Self-Efficacy

Timeframe: 2 weeks after from baseline

Trial details

NCT IDNCT07032402

SponsorAmasya University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-25

View on ClinicalTrials.gov More Sudden Infant Death Syndrome trials

Who can participate

Age range

18 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Knowledge

Timeframe: baseline (first assessment)

Knowledge

Timeframe: 2 weeks after from baseline

Knowledge

Timeframe: at the end of the invervention program (4 weeks after from baseline)

Care Skills

Timeframe: baseline (first assessment)

Care Skills

Timeframe: 2 weeks after from baseline

Care Skills

Timeframe: at the end of the invervention program (4 weeks after from baseline)

Self-Efficacy

Timeframe: baseline (first assessment)

Self-Efficacy

Timeframe: 2 weeks after from baseline